Medicare Enrolled
Dr. Frank Coletta, MD
Pulmonary Disease · Rockville Centre, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Coletta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coletta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Coletta
Dr. Frank Coletta is a pulmonary disease specialist in Rockville Centre, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Coletta performed 4,362 Medicare services across 3,021 unique beneficiaries.
Between the years covered by Open Payments, Dr. Coletta received a total of $28,218 from 64 pharmaceutical and/or device companies across 961 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Coletta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in NY
$28,218 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,362
Medicare services
Top 6% in NY for pulmonary disease
3,021
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~230 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
937 | $73 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
647 | $116 | $167 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
413 | $201 | $709 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
367 | $81 | $118 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
174 | $36 | $55 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
174 | $9 | $15 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
172 | $55 | $78 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
171 | $15 | $22 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
168 | $110 | $164 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
167 | $53 | $73 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
160 | $161 | $230 |
| Hemoglobin measurement A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
156 | $5 | $35 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $158 | $219 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
70 | $36 | $50 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
64 | $101 | $458 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
59 | $76 | $100 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
56 | $69 | $199 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
55 | $24 | $37 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
43 | $152 | $168 |
| Exercise test for lung airway spasm A test performed during physical activity to check for spasms in the lung airways. |
42 | $72 | $100 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
34 | $124 | $169 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
29 | $13 | $19 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
28 | $42 | $122 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
26 | $18 | $26 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
21 | $15 | $24 |
| Annual depression screening | 21 | $22 | $24 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
13 | $169 | $229 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
11 | $245 | $277 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$28,218
Total received (2018-2024)
Avg $4,031/year across 7 years
Top 9% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
961
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,476 (79.7%)
Other
Charitable contributions, space rental, and other categories
$3,557 (12.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,851 (6.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$334 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,392
2023
$4,357
2022
$4,343
2021
$3,165
2020
$3,826
2019
$4,071
2018
$3,063
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Philips North America LLC
$1,251
AstraZeneca Pharmaceuticals LP
$1,201
GlaxoSmithKline, LLC.
$981
Fisher & Paykel Healthcare Inc
$347
JAZZ PHARMACEUTICALS INC.
$343
HARMONY BIOSCIENCES LLC
$224
Regeneron Healthcare Solutions, Inc.
$154
Actelion Pharmaceuticals US, Inc.
$133
Inspire Medical Systems, Inc.
$114
Amgen Inc.
$80
ZOLL Respicardia, Inc.
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Harmony Biosciences Llc
$54
Baxter Healthcare
$51
Mylan Specialty L.P.
$49
Grifols USA, LLC
$47
GENZYME CORPORATION
$40
Shionogi Inc
$28
Merck Sharp & Dohme LLC
$26
INOGEN, INC.
$25
Janssen Pharmaceuticals, Inc
$25
Electromed, Inc.
$23
3B Medical, Inc.
$21
United Therapeutics Corporation
$21
PFIZER INC.
$20
Insmed, Inc.
$18
Top 3 companies account for 63.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$4,557
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,279
AstraZeneca Pharmaceuticals LP
$4,234
Philips Electronics North America Corporation
$3,028
Philips North America LLC
$1,251
JAZZ PHARMACEUTICALS INC.
$978
Mylan Specialty L.P.
$673
PFIZER INC.
$649
Harmony Biosciences LLC
$587
HARMONY BIOSCIENCES LLC
$559
Regeneron Healthcare Solutions, Inc.
$525
Actelion Pharmaceuticals US, Inc.
$472
GENZYME CORPORATION
$400
Grifols USA, LLC
$372
Jazz Pharmaceuticals Inc.
$365
Fisher & Paykel Healthcare Inc
$363
Amgen Inc.
$359
Mallinckrodt Hospital Products Inc.
$310
Vapotherm Inc
$270
Janssen Pharmaceuticals, Inc
$254
Sunovion Pharmaceuticals Inc.
$246
CHIESI USA, INC.
$236
Regeneron Pharmaceuticals, Inc.
$230
Takeda Pharmaceuticals U.S.A., Inc.
$222
Electromed, Inc.
$219
Inari Medical, Inc.
$212
Olympus America Inc.
$186
IDORSIA PHARMACEUTICALS US INC
$168
Baxter Healthcare
$156
Advanced Respiratory, Inc
$149
Neurocrine Biosciences, Inc.
$136
Shionogi Inc
$127
Chiesi USA, Inc.
$127
Inspire Medical Systems, Inc.
$114
Genentech USA, Inc.
$108
Covidien LP
$97
Novartis Pharmaceuticals Corporation
$75
Teva Pharmaceuticals USA, Inc.
$71
Merck Sharp & Dohme LLC
$70
Circassia Pharmaceuticals Inc
$64
ZOLL Respicardia, Inc.
$58
Itamar Medical Inc
$56
Harmony Biosciences Llc
$54
ADVANCED RESPIRATORY, INC
$52
Inogen, Inc.
$46
E.R. Squibb & Sons, L.L.C.
$46
Gilead Sciences, Inc.
$44
Phadia US Inc.
$34
AbbVie Inc.
$27
INOGEN, INC.
$25
Mallinckrodt LLC
$23
Paratek Pharmaceuticals, Inc.
$23
Arbor Pharmaceuticals, Inc.
$22
Lilly USA, LLC
$22
3B Medical, Inc.
$21
ARBOR PHARMACEUTICALS, INC.
$21
United Therapeutics Corporation
$21
Otsuka America Pharmaceutical, Inc.
$20
Allergan Inc.
$19
Merck Sharp & Dohme Corporation
$19
ABBVIE INC.
$18
Insmed, Inc.
$18
La Jolla Pharmaceutical Company
$18
BAXTER HEALTHCARE
$15
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8269) DreamStation Cpap · (8359) DreamWear Pillows · (8874) inCourage · (8944) Trilogy Evo Univ · (8944) Trilogy Evo Universal · (AK6) Vest Therapy · (O58) Sleep Respiratory Care Und · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CAPVAXIVE · CLEVIPREX · CLEVIPREX 25MG/50ML · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamWear · DreamWear Pillows · Dreamstat Bipap Auto · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · Fetroja · FlowTriever · GIAPREZA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INGREZZA · INOGEN AT HOME STATIONARY CONCENTRATOR · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · JARDIANCE · KENGREAL · LOKELMA · LONHALA MAGNAIR · LUNA · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Olympus Respiratory Accessories · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Perforomist · Precision Flow · Prolastin-C Liquid · QUVIVIQ · Renal - CRRT · Respiratoriy Care Undiv · S · SAMSCA · SEEBRI · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sleep Other · TEFLARO · TERLIVAZ · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VAPOTHERM · WAKIX · Wakix · WatchPAT · Wellcentive Undiv · XARELTO · XGEVA · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage · remede System · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
538
Per 100K population
38.8
County median income
$143,408
Nearest hospital
MOUNT SINAI SOUTH NASSAU
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Coletta is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NY), with low-engagement industry engagement in the top 9% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Coletta experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Coletta performed 937 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Coletta receive payments from pharmaceutical companies?
Yes. Dr. Coletta received a total of $28,218 from 64 companies across 961 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coletta's costs compare to other pulmonary diseases in Rockville Centre?
Dr. Coletta's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coletta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Rockville Centre
Browse pulmonary diseases in Rockville Centre ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology